Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya Marshall-Gradisnik

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Public Health|September 25, 2020
The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian CohortShara Close, Sonya Marshall-Gradisnik, Joshua Byrnes, et al.
Journal of Translational Medicine|July 16, 2021
The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP<sub>2</sub> and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patientsNatalie Eaton-Fitch, Hélène Cabanas, Stanley du Preez, et al.
The Application of Clinical Genetics|April 22, 2016
Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndromeSonya Marshall-Gradisnik, Teilah Huth, Anu Chacko, et al.
The Journal of International Medical Research|November 12, 2016
Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patientsSonya Marshall-Gradisnik, Samantha Johnston, Anu Chacko, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2025
Analysis of Transient Receptor Potential Ion Channels in ME/CFSNatalie Eaton-Fitch, Katsuhiko Muraki, Etianne Martini Sasso, et al.
Frontiers in Immunology|July 30, 2021
Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and TreatmentHelene Cabanas, Katsuhiko Muraki, Natalie Eaton-Fitch, et al.
International Journal of Environmental Research and Public Health|November 27, 2021
Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP<sub>2</sub> in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome PatientsStanley Du Preez, Natalie Eaton-Fitch, Helene Cabanas, et al.
Journal of Translational Medicine|February 18, 2021
A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndromeRebekah Maksoud, Cassandra Balinas, Sean Holden, et al.
Health Care for Women International|October 16, 2014
Severity Scales for Use in Primary Health Care to Assess Chronic Fatigue Syndrome/Myalgic EncephalomyelitisSharni Lee Hardcastle, Ekua Weba Brenu, Samantha Johnston, et al.
Systematic Reviews|November 16, 2019
A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndromeNatalie Eaton-Fitch, Stanley du Preez, Hélène Cabanas, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Public Health|September 25, 2020
The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian CohortShara Close, Sonya Marshall-Gradisnik, Joshua Byrnes, et al.
Journal of Translational Medicine|July 16, 2021
The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP<sub>2</sub> and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patientsNatalie Eaton-Fitch, Hélène Cabanas, Stanley du Preez, et al.
The Application of Clinical Genetics|April 22, 2016
Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndromeSonya Marshall-Gradisnik, Teilah Huth, Anu Chacko, et al.
The Journal of International Medical Research|November 12, 2016
Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patientsSonya Marshall-Gradisnik, Samantha Johnston, Anu Chacko, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2025
Analysis of Transient Receptor Potential Ion Channels in ME/CFSNatalie Eaton-Fitch, Katsuhiko Muraki, Etianne Martini Sasso, et al.
Frontiers in Immunology|July 30, 2021
Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and TreatmentHelene Cabanas, Katsuhiko Muraki, Natalie Eaton-Fitch, et al.
International Journal of Environmental Research and Public Health|November 27, 2021
Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP<sub>2</sub> in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome PatientsStanley Du Preez, Natalie Eaton-Fitch, Helene Cabanas, et al.
Journal of Translational Medicine|February 18, 2021
A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndromeRebekah Maksoud, Cassandra Balinas, Sean Holden, et al.
Health Care for Women International|October 16, 2014
Severity Scales for Use in Primary Health Care to Assess Chronic Fatigue Syndrome/Myalgic EncephalomyelitisSharni Lee Hardcastle, Ekua Weba Brenu, Samantha Johnston, et al.
Systematic Reviews|November 16, 2019
A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndromeNatalie Eaton-Fitch, Stanley du Preez, Hélène Cabanas, et al.
Pageof 9